“CST is committed to developing new rigorously validated antibodies and protein tools”

BioSpectrum Asia|June 2020

“CST is committed to developing new rigorously validated antibodies and protein tools”
The United States-based Cell Signaling Technology (CST) is a global, private, family-owned company founded by scientists in 1999. CST supplies the highest quality antibodies and reagents to enable researchers to discover the mechanisms of disease. It didn’t believe in compromising science for profits. That’s why it produces and validate its products in-house. BioSpectrum Asia spoke to Roberto Polakiewcz, Chief Scientific Officer, Cell Signaling Technology (CST), Danvers, United States, who drives research, product, and technology innovation, facilitating the creation of CST’s most valuable products, technologies, and intellectual property on the company’s contributions in tacking COVID-19 and plans for expansion in Asian region?
Ankit Kankar

How is CST contributing towards tackling the COVID-19 pandemic?

Cell Signaling Technology (CST) has and is rapidly expanding a portfolio of research use antibodies, proteins, and tools to build assays that can be used for creating viral and serological tests and studying mechanisms of SARS-CoV-2 infection and host-immune response. These products enable researchers around the globe to understand the biology and pathology of the virus, so their efforts to develop reliable serological tests, therapeutic treatments, and vaccines can move forward quickly. There has been an incredibly rapid effort to build tests to help fight the COVID-19 pandemic. Unfortunately, as we read in the news, speed often comes at the expense of quality. Global research efforts have to move fast, but the scientific and medical community can’t afford to waste time on assays and experiments that used poorly validated reagents, or worse yet come to an erroneous conclusion. So, CST is committed to developing new rigorously validated antibodies and protein tools to important targets of COVID-19 pathology and immunology. Validation is always important, but it is especially crucial now to ensure that reagents are accurate and reliable. At CST, we are stepping forward in solidarity with the scientific community to fight this disease the best way we know how, based on quality and scientific rigor.


You can read up to 3 premium stories before you subscribe to Magzter GOLD

Log in, if you are already a subscriber


Get unlimited access to thousands of curated premium stories and 5,000+ magazines


June 2020